3
Views
1
CrossRef citations to date
0
Altmetric
Symposium Myocardial infarction: THROMBOLYTIC THERAPY

Thrombolytic therapy for acute myocardial infarction

Are inclusion criteria too stringent?

Pages 77-82 | Published online: 05 Dec 2017

References

  • Cole PL. Thrombolytic therapy: then and now. Heart Lung 1991; 20(5 Pt 2): 542–51
  • Gruppo Italiano per lo Studio della Strep-tochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1(8478): 397–402
  • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990; 336(8707): 65–71
  • Wall TC, Califf RM, George BS, et al. Accelerated plasminogen activator dose regimens for coronary thrombolysis. J Am Coll Cardiol 1992; 19(3): 482–9
  • The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329(10): 673–82
  • Wilcox RG, von der Lippe G, Olsson CG, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988; 2(8610): 525–30
  • Murray N, Lyons J, Layton C, et al. What proportion of patients with myocardial infarction are suitable for thrombolysis? Br Heart J 1987; 57(2): 144–7
  • Jagger JD, Murray RG, Davies MK, et al. Eligibility for thrombolytic therapy in acute myocardial infarction. Lancet 1987: 1(8523): 34–5 [erratum, Lancet 1987; 1(8528): 336]
  • Grines CL, DeMaria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol 1990; 16(1): 223–31
  • The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med 1989; 320(10): 618–27
  • ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2(8607): 349–60
  • O'Connor CM, Califf RM, Topol EJ, et al. Stroke and acute myocardial infarction: new trends and unpredictability in the thrombolytic era. Circulation 1988; 78(Suppl II): II509

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.